医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

Acucela Announces Initiation of Phase 2b

Acucela Announces Initiation of Phase 2b/3 Clinical Trial of Emixustat Hydrochloride (formerly known as ACU-4429) in Subjects with Geographic Atrophy (GA) Associated with Dry Age-Related Macular Degeneration (AMD)

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: Acucela Announces Initiation of Phase 2b Associated with Dry Age-Related Macular Emixustat Hydrochloride formerly known as ACU-4429 Geographic Atrophy

2013年04月25日